These side effects are usually mild to moderate and typically resolve within a few days to a few weeks* * Individual results may vary Semaglutide or Tirzepatide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
A research-grade BPC-157 COA should show an HPLC chromatogram with a purity percentage of 99% or higher, mass spectrometry confirming identity matching the GEPPPGKPADDAGLV sequence (molecular weight 1419 Da), a batch or lot number, testing date, and analytical laboratory name
Tirzepatide is typically prescribed for individuals with type 2 diabetes who also need to manage their weight, and for those with obesity or overweight with at least one weight-related comorbidity
You are primarily managing blood sugar with weight loss as a secondary goal
Frequently Asked Questions What blood tests should be checked while taking semaglutide
The pen is designed for single-patient use and provides precise dose delivery with a simple dial-a-dose mechanism